Abstract
The field of metabolomics has been growing tremendously over the recent years and, consistent with that growth, a number of investigators have been looking at the potential of NMR-based urinary metabolomics for several applications. While such applications have shown promising results, there still remains an enormous amount of work to be done before this approach becomes accepted and widely used in clinical diagnostics and other biomedical applications. To achieve such goals, optimization of parameters and standardization of protocols are of paramount importance. In view of this, in this chapter, we present some recommended methods and procedures that can help researchers in the field. Furthermore, we have highlighted some of the challenges encountered in such applications and suggested some possible ways to overcome those challenges.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beckonert O, Keun H, Ebbels T, Bundy J, Holmes E, Lindon J, Nicholson J (2007) Metabolic profiling, metabolomics and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2(11):2692–2703. https://doi.org/10.1038/nprot.2007.376
Roessner U, Bowne J (2009) What is metabolomics all about? BioTechniques 46:363–365. https://doi.org/10.2144/000113133
Van QN, Veenstra TD, Issaq HJ (2011) Metabolic profiling for the Detection of Bladder Cancer. Curr Urol Rep 12(1):34–40
Duarte LF, Gil AM (2012) Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. Prog Nucl Magn Reson Spectrosc 62:51–74
Fiehn O (2002) Metabolomics—the link between genotypes and phenotypes. Plant Mol Biol 48(1-2):155–171
Weckweth W (2003) Metabolomics in Systems Biology. Annu Rev Plant Biol 54:669–689
Duarte L, Diaz S, Gil A (2014) NMR metabolomics of human blood and urine in disease research. J Pharm Biomed Anal 93:17–26. https://doi.org/10.1016/j.jpba.2013.09.025
Bouatra S, Aziat F, Guo AC et al (2013) The Human Urine Metabolome. PLoS One 8(9):e73076. https://doi.org/10.1371/journal.pone.0073076
Kim K, Aronov P, Zakharkin S (2008) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8:558–570. https://doi.org/10.1074/mcp.M800165-MCP2000
Serkova NJ, Niemann CU (2006) Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn 6(5):717–731. https://doi.org/10.1586/14727159.6.5.717
Dunn W, Bailey N, Johnson H (2005) Measuring the metabolome: current analytical technologies. Analyst 130:606–625
Lehman-McKeeman LD, Car B (2004) Metabonomics: application in predictive and mechanistic toxicology. Toxicol Pathol 32:94–96. https://doi.org/10.1080/01926230490462084
Wishart DS, Feunang YD, Marcu A et al (2018) (2013) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46(D1):D608–D617. https://doi.org/10.1093/nar/gkx1089
Lauridsen M, Hansen SH, Jaroszewski JW, Cornnet C (2007) Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage. Anal Chem 79(3):1181–1186. https://doi.org/10.1021/ac061354x
Vitols C, Fu H (2006) Targeted profiling of common metabolites in urine. Chenomx, Edmonton, Alberta
Rosewell R, Vitols C (2006) Identifying metabolites in biofluids. Chenomx Inc, Edmonton, Alberta
Liu L, Mo H, Wei S, Raftery D (2012) Quantitative analysis of urea in human urine and serum by 1H nuclear magnetic resonance. Analyst 137(3):595–600. https://doi.org/10.1039/c2an15780b
Tang KW, Toh QC, Teo BW (2015) Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why. Singapore Med J 56(1):7–10. https://doi.org/10.11622/smedj.2015003
Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78(13):4430–4442. https://doi.org/10.1021/ac060209g
Chenomx NMR suite. http://www.chenomx.com/software/software.php
Hao J, Liebeke M, Astle W, De lorio M, Bundy JG, Ebbels TM (2015) Bayesian deconvolution and quantification of metabolites in complex 1D NMR spectra using BATMAN. Nat Protoc 9(6):1416–1427. https://doi.org/10.1038/nprot.2014.090
Friedrich N, Budde K, Suhre K, Volker U, John U, Felix SB et al (2015) Sex differences in urine metabolites related with risk of diabetes using NMR spectroscopy: results of the study of health in Pomerania. Metabolomics 11:1405–1415
Barker M, Ravens W (2003) Partial least squares for discrimination. J Chemom 3:166–173
Eriksson L, Johansson E, Kettaneh-Wold N, World S (2001) Multi- and megavariate data analysis-principles and applications. Umetrics Academy, Dublin OH
Jackson JE (1991) A user’s guide to principal components. Wiley, New York
Nikulin AE, Dolenko B, Bezabeh T, Somoriaj RL (1998) Near-optimal region selection for feature space reduction: novel-preprocessing methods for classifying NMR spectra. NMR Biomed 11:209–216
Xiao J, Wishart DS (2011) Web-based inference of biological patterns, functions, and pathways from metabolomics data using metaboanlayst. Nat Protoc 6:743–760. https://doi.org/10.1038/nprot.2011.319
Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J et al (2008) BioMagResBank. Nucleic Acids Res 36:D402–D408. https://doi.org/10.1093/nar/gkm957
Ludwig C, Easton JM, Lodi A, Tiziani S, Manzoor SE, Southam AD et al (2012) Birmingham metabolite library. Metabolomics 8:8–18. https://doi.org/10.1007/s11306-011-0347-7
Capati A, Ijare OB, Bezabeh T (2017) Diagnostic applications of nuclear magnetic resonance-based urinary metabolomics. Magn Reson Insights 10:1178623X17694346. https://doi.org/10.1177/1178623X17694346
Rasmussen LG, Winning H, Savorani F et al (2012) Assessment of the effect of high or low protein diet on the human urine metabolome as measured by NMR. Nutrients 4(2):112–131. https://doi.org/10.3390/nu4020112
Lenz EM, Bright J, Wilson I et al (2004) Metabonomics, dietary influences and cultural differences: NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal 36(4):841–849. https://doi.org/10.1016/j.pba.2004.08.002
Dumas ME, Maibaum EC, Teague C et al (2006) Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal Chem 78(7):2199–2208
Zuppi C, Messana I, Forni F, Ferrari F, Rossi C, Giardina B (1998) Influence of feeding on metabolite excretion evidenced by urine 1H NMR spectral profiles: a comparison between subjects living in Rome and subjects living at arctic latitudes (Svaldbard). Clin Chim Acta 278:75–79
Jakobsen LM, Yde CC, Van Hecke T et al (2017) Impact of red meat consumption on the metabolome of rats. Mol Nutr Food Res 61(3). https://doi.org/10.1002/mnfr.201600387
Slupsky CM, Rankin KN, Wagner J et al (2007) Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomics. Anal Chem 79(18):6995–7004
Psihogios N, Gazi I, Elisaf M, Seferiadis K, Bairaktari E (2008) Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 21:195–207. https://doi.org/10.1002/nbm.1176
Rist MJ, Muhle-Goll C, Gorling B, Bub A, Heissler S, Watzl B, Luy B (2012) Influence of freezing and storage procedure on human urine samples in NMR-based metabolomics. Metabolites 3:243–258. https://doi.org/10.3390/metabo3020243
Saude EJ, Sykes BD (2007) Urine stability for metabolomics studies: effects of preparation and storage. Metabolomics 3:19–27. https://doi.org/10.1007/s11306-006-0042-2
Rotter M, Brandmaier S, Prehn C et al (2017) Stability of targeted metabolite profiles of urine samples under different storage conditions. Metabolomics 13(1):4. https://doi.org/10.1007/s11306-016-1137-z
Keun HC, Ebbels TM, Antti H, Bollard ME, Beckonert O, Scholtterbeck G (2002) Analytical reproducibility in (1) H NMR-based metabonomic urinalysis. Chem Res Toxicol 15(11):1380–1386
Da Silva L, Godejohann M, Martin FP et al (2013) High –resolution quantitative metabolome analysis of urine by automated flow injection NMR. Anal Chem 84(12):5801–5809. https://doi.org/10.1021/ac4004776
Miyataka H, Ozaki T, Himeno S (2007) Effect of pH on 1H-NMR spectroscopy of mouse urine. Biol Pharm Bull 30(4):667–670
Emwas AH, Luchinat C, Turano P, Tenori P, Roy R, Salek RM et al (2015) Standardizing the experimental conditions for using urine in NMR-based metabolomics studies with a particular focus on diagnostic studies: a review. Metabolomics 11(4):872–894. https://doi.org/10.1007/s11306-014-0746-7
Giraudeau P, Silvestre V, Akoka S (2015) Optimizing water suppression for quantitative NMR-based metabolomics: a tutorial review. Metabolomics 11:1041–1055. https://doi.org/10.1007/s11306-015-0794-7
Emwas AH, Roy R, McKay RT et al (2016) Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis. J Proteome Res 15(2):360–373. https://doi.org/10.1021/acs.jproteome.5b00885
Le Guennec A, Tayyari F, Edison AS (2017) Alternatives to Nuclear Overhauser Enhancement Spectroscopy Presat and Carr—Purcell—Meiboom—Gill Presat for NMR-Based Metabolomics. Anal Chem 89(17):8582–8588. https://doi.org/10.1021/acs.analchem.7b02354
Hertl J, Rotter M, Frenzel S et al (2018) Dilution correction for dynamically influenced urinary analyte data. Anal Chim Acta 1032:18–31. https://doi.org/10.1016/j.aca.2018.07.068
Tredwell GD, Bundy JG, De lorio M, Ebbels TMD (2016) Modelling the acid/base 1H NMR chemical shift limits of metabolites in human urine. Metabolomics 12(10):152. https://doi.org/10.1007/s11306-016-1101-y
Cl L, Somorjai RL, Smith ICP, Russell P, Mountford CE (2002) Accurate diagnosis and prognosis of human cancers by proton MRS and a three-stage classification strategy. Annu Rep NMR Spectro 48:71–111
Bezabeh T, Somorjai RL, Dolenko B et al (2009) Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts. NMR Biomed 22:593–600
Bezabeh T, Ijare OB, NIkulin AE, Somoriai R, Smith ICP (2014) MRS-based metabolomics in cancer research. Magn Reson Insights 7:1–14
Somorjai RL, Nikulin AE, Pizzi N et al (1995) Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. Application to 1H spectra of thyroid neoplasms. Magn Reson Med 33:257–263
Somorjai RL, Dolenko B, Nikulin AK et al (1996) Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing computerized consensus diagnosis on classification accuracy. J Magn Reson Imaging 6:437–433
Dona AC, Kyriakides M, Scott F, Shephard EA, Varshavi D, Veselkov K, Everett JR (2016) A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments. Comput Struct Biotechnol 12:135–153. https://doi.org/10.1016/j.csbj.2016.02.005
Everett JR (2015) A new paradigm for known metabolite identification in metabonomics/metabolomics: metabolite identification efficiency. Comput Struct Biotechnol 13:131–144. https://doi.org/10.1016/j.csbj.2015.01.002
Oman T, Tessem MB, Bathen TF, Bertilsson H, Angelsen A, Hedenstrom M, Andreassen T (2014) Identification of metabolites from 2D (1) H-(13)C HSQC NMR using peak correlation plots. Bioinformatics 15:413. https://doi.org/10.1186/s12859-014-0413-z
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bezabeh, T., Capati, A., Ijare, O.B. (2019). NMR-Based Urinary Metabolomics Applications. In: Gowda, G., Raftery, D. (eds) NMR-Based Metabolomics. Methods in Molecular Biology, vol 2037. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9690-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9690-2_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9689-6
Online ISBN: 978-1-4939-9690-2
eBook Packages: Springer Protocols